HH
GYRE icon

HSG Holding’s Gyre Therapeutics GYRE Stock Holding History

HSG Holding’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7M Buy
+3,750,299
New +$25.5M 2.06% 6

Other funds holding GYRE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HSG Holding's GYRE Position: Q2 2026 in Review

HSG Holding opened a new position in Gyre Therapeutics (GYRE) in Q2 2026: 3,750,299 shares worth $24.7M. The stake represents 2.06% of the portfolio and ranks #6 among its holdings.

46 funds tracked by Wall St. Rank hold GYRE as of Q2 2026.

  • HSG Holding held 3,750,299 shares of Gyre Therapeutics worth $24.7M as of Q2 2026.
  • Gyre Therapeutics was a new HSG Holding position in Q2 2026.
  • Gyre Therapeutics made up 2.06% of HSG Holding's portfolio in Q2 2026, its #6 holding.
  • 46 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2026.

Based on HSG Holding's 13F filing for Q2 2026, filed 13 Aug 2026.